1. Home
  2. AXSM vs SFBS Comparison

AXSM vs SFBS Comparison

Compare AXSM & SFBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • SFBS
  • Stock Information
  • Founded
  • AXSM 2012
  • SFBS 2005
  • Country
  • AXSM United States
  • SFBS United States
  • Employees
  • AXSM N/A
  • SFBS N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • SFBS Major Banks
  • Sector
  • AXSM Health Care
  • SFBS Finance
  • Exchange
  • AXSM Nasdaq
  • SFBS Nasdaq
  • Market Cap
  • AXSM 4.0B
  • SFBS 4.4B
  • IPO Year
  • AXSM 2015
  • SFBS 2014
  • Fundamental
  • Price
  • AXSM $93.19
  • SFBS $76.64
  • Analyst Decision
  • AXSM Strong Buy
  • SFBS Hold
  • Analyst Count
  • AXSM 14
  • SFBS 2
  • Target Price
  • AXSM $125.67
  • SFBS $67.00
  • AVG Volume (30 Days)
  • AXSM 427.1K
  • SFBS 157.1K
  • Earning Date
  • AXSM 11-04-2024
  • SFBS 10-14-2024
  • Dividend Yield
  • AXSM N/A
  • SFBS 1.57%
  • EPS Growth
  • AXSM N/A
  • SFBS N/A
  • EPS
  • AXSM N/A
  • SFBS 3.62
  • Revenue
  • AXSM $291,489,000.00
  • SFBS $412,135,000.00
  • Revenue This Year
  • AXSM $42.50
  • SFBS N/A
  • Revenue Next Year
  • AXSM $69.28
  • SFBS $15.03
  • P/E Ratio
  • AXSM N/A
  • SFBS $21.17
  • Revenue Growth
  • AXSM 59.73
  • SFBS N/A
  • 52 Week Low
  • AXSM $55.02
  • SFBS $45.21
  • 52 Week High
  • AXSM $98.40
  • SFBS $83.61
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 64.50
  • SFBS 48.37
  • Support Level
  • AXSM $88.04
  • SFBS $77.29
  • Resistance Level
  • AXSM $97.00
  • SFBS $80.13
  • Average True Range (ATR)
  • AXSM 3.03
  • SFBS 2.30
  • MACD
  • AXSM 0.49
  • SFBS -0.45
  • Stochastic Oscillator
  • AXSM 64.58
  • SFBS 6.50

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About SFBS ServisFirst Bancshares Inc.

Servisfirst Bancshares Inc is a bank holding company. It originates commercial, consumer, and other loans and accepts deposits, provides electronic banking services, such as online and mobile banking, including remote deposit capture, delivers treasury and cash management services, and provides banking services to other financial institutions. The company offers services which include telephone banking, direct deposit, Internet banking, mobile banking, boxes, and automatic account transfers.

Share on Social Networks: